Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Crit Rev Oncog. 2014;19(0):121–132. doi: 10.1615/critrevoncog.2014010931

TABLE 1.

NK cell content in apheresis products

Apheresis product source TNC (×106) CD45+CD56+CD3- NKs (%) Absolute number of NKs (×106)
Healthy donor 6222 4 249
Healthy donor 21600 4 864
Healthy donor 16328 7 1143
Healthy donor 21200 10 2120
Myeloma patient 7181 17 1221
Myeloma patient 11368 13 1478
Myeloma patient 10560 16 1690
Myeloma patient 35088 10 3509
Myeloma patient 14190 36 5108
Average±StDev 15971±9018 13±10 1931±1499